PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Schizophrenia 77,034 Disease Target ACAT2 145 1 0.00 -1.00 0.01 0.54
Cancer 1,053,491 Disease Target ACAD8 11 1 0.00 -0.95 0.09 0.54
Cancer 1,053,491 Disease Target AACT 109 12 0.00 -0.94 0.11 0.55
Carcinoma 433,099 Disease Target AACT 109 5 0.00 -0.98 0.05 0.55
Poisoning 53,779 Disease Target AACT 109 3 0.00 -0.99 0.03 0.58
Platelet Aggregation 25,460 Disease Target AACT 109 1 0.00 -1.00 0.01 0.58
Colon Cancer 30,064 Disease Target AACT 109 1 0.00 -1.00 0.01 0.57
Lung Cancer 91,416 Disease Target AACT 109 1 0.00 -1.00 0.01 0.55
Bronchitis 18,336 Disease Target AACT 109 1 0.00 -1.00 0.01 0.58
Diabetes 332,602 Disease Target AACT 109 1 0.00 -1.00 0.01 0.52
Hormone Replacement Therapy 11,020 Disease Target AACT 109 1 0.00 -1.00 0.01 0.60
Social Anxiety 3,287 Disease Target AACT 109 1 0.00 -1.00 0.01 0.63
Hearing Loss 30,622 Disease Target AACT 109 1 0.00 -1.00 0.01 0.57
Osteoarthritis 36,287 Disease Target AACT 109 1 0.00 -1.00 0.01 0.57
Anxiety 113,510 Disease Target AACT 109 1 0.00 -1.00 0.01 0.54
Prostate Cancer 71,064 Disease Target AACT 109 1 0.00 -1.00 0.01 0.55
Tuberculosis 146,217 Disease Target AACT 109 1 0.00 -1.00 0.01 0.54
Chronic Obstructive Pulmonary Disease 27,780 Disease Target AACT 109 1 0.00 -1.00 0.01 0.57
Infection 766,637 Disease Target AACT 109 1 0.00 -1.00 0.01 0.50
Diabetes 332,602 Disease Target A1M 59 4 0.00 -0.97 0.07 0.56
Albuminuria 6,831 Disease Target A1M 59 3 0.00 -0.97 0.05 0.65
Hemorrhage 100,979 Disease Target A1M 59 2 0.00 -0.98 0.03 0.57
Cancer 1,053,491 Disease Target A1AT 329 34 0.00 -0.95 0.10 0.55
Carcinoma 433,099 Disease Target A1AT 329 22 0.00 -0.97 0.07 0.56
Chronic Obstructive Pulmonary Disease 27,780 Disease Target A1AT 329 22 0.01 -0.97 0.07 0.64
Infection 766,637 Disease Target A1AT 329 16 0.00 -0.98 0.05 0.54
Lung Cancer 91,416 Disease Target A1AT 329 7 0.00 -0.99 0.02 0.57
Hepatitis B 57,815 Disease Target A1AT 329 6 0.00 -0.99 0.02 0.58
Glomerulonephritis 23,459 Disease Target A1AT 329 6 0.00 -0.99 0.02 0.60
Bronchitis 18,336 Disease Target A1AT 329 4 0.00 -0.99 0.01 0.60
Obesity 138,233 Disease Target A1AT 329 4 0.00 -0.99 0.01 0.55
Sedimentation Rate 11,455 Disease Target A1AT 329 3 0.00 -1.00 0.01 0.60
Bladder Cancer 21,509 Disease Target A1AT 329 3 0.00 -1.00 0.01 0.59
Pneumonia 81,521 Disease Target A1AT 329 3 0.00 -1.00 0.01 0.55
Diabetes 332,602 Disease Target A1AT 329 2 0.00 -1.00 0.01 0.51
Hemorrhage 100,979 Disease Target A1AT 329 2 0.00 -1.00 0.01 0.54
Adult Respiratory Distress Syndrome 4,034 Disease Target A1AT 329 2 0.00 -1.00 0.01 0.62
Hyperbilirubinemia 5,757 Disease Target A1AT 329 2 0.00 -1.00 0.01 0.61
Shock 134,031 Disease Target A1AT 329 2 0.00 -1.00 0.01 0.53
Colon Cancer 30,064 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Non Small Cell Lung Cancer 28,563 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Cervical Cancer 28,286 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Osteoarthritis 36,287 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.55
Fibromyalgia 6,837 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.59
Anxiety 113,510 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.52
Tuberculosis 146,217 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.51
Diarrhea 51,986 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.54
Kidney Diseases 4,651 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.60
Multiple Myeloma 24,594 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.56
Influenza 67,933 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.53
Analgesia 44,857 Disease Target 744.1 22 1 0.00 -0.98 0.05 0.59
Diabetes 332,602 Disease Target 744.1 22 1 0.00 -0.98 0.05 0.55
Obesity 138,233 Disease Target 5-Hydroxytryptamine 6 Receptor 12 1 0.00 -0.96 0.08 0.57
Schizophrenia 77,034 Disease Target 5-Hydroxytryptamine 2a Receptor 67 10 0.00 -0.92 0.15 0.61
Depression 220,092 Disease Target 5-Hydroxytryptamine 2a Receptor 67 5 0.00 -0.96 0.07 0.57
Platelet Aggregation 25,460 Disease Target 5-Hydroxytryptamine 2a Receptor 67 3 0.00 -0.98 0.04 0.61
Insomnia 12,434 Disease Target 5-Hydroxytryptamine 2a Receptor 67 3 0.00 -0.98 0.04 0.63
Obesity 138,233 Disease Target 5-Hydroxytryptamine 2a Receptor 67 2 0.00 -0.98 0.03 0.56
Hyperglycemia 28,168 Disease Target 5-Hydroxytryptamine 2a Receptor 67 2 0.00 -0.98 0.03 0.60
Analgesia 44,857 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
Seizure 44,685 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
Diabetes 332,602 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.53
Cancer 1,053,491 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.51
Anxiety 113,510 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.55
Infection 766,637 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.51
Eating Disorders 9,000 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.61
Arthritis 128,324 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.55
Obsessive Compulsive Disorder 8,508 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.61
Headache 50,687 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
Attention Deficit Hyperactivity Disorder 14,687 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.60
Rheumatoid Arthritis 78,952 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.56
Cancer 1,053,491 Disease Target 464.1 19 2 0.00 -0.95 0.11 0.54
Diabetes 332,602 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.55
Carcinoma 433,099 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.54
Prostate Cancer 71,064 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.58
Acute Promyelocytic Leukemia 4,780 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.65
Renal Failure 73,993 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.58
Cancer 1,053,491 Disease Drug 4-Mercaptobenzoic Acid 70 4 0.00 -0.97 0.06 0.53
Hepatitis B 57,815 Disease Drug 4-Mercaptobenzoic Acid 70 2 0.00 -0.99 0.03 0.58
Carcinoma 433,099 Disease Drug 4-Mercaptobenzoic Acid 70 1 0.00 -0.99 0.01 0.52
Dehydration 21,928 Disease Drug 4-Mercaptobenzoic Acid 70 1 0.00 -0.99 0.01 0.59
Cancer 1,053,491 Disease Target 4-1BB Receptor 20 5 0.00 -0.87 0.25 0.56
Carcinoma 433,099 Disease Target 4-1BB Receptor 20 3 0.00 -0.92 0.15 0.56
Graft Versus Host Disease 15,741 Disease Target 4-1BB Receptor 20 2 0.00 -0.95 0.10 0.63
Cancer 1,053,491 Disease Target 4-1BB Ligand 135 27 0.00 -0.89 0.20 0.56
Carcinoma 433,099 Disease Target 4-1BB Ligand 135 14 0.00 -0.95 0.10 0.57
Infection 766,637 Disease Target 4-1BB Ligand 135 11 0.00 -0.96 0.08 0.55
Graft Versus Host Disease 15,741 Disease Target 4-1BB Ligand 135 2 0.00 -0.99 0.01 0.60
Colon Cancer 30,064 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.57
Diabetes 332,602 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.52
Obesity 138,233 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.53
Cervical Cancer 28,286 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.57
Conjunctivitis 8,825 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.60
Diabetes 332,602 Disease Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 9 0.00 -0.98 0.04 0.55
Lung Cancer 91,416 Disease Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 4 0.00 -0.99 0.02 0.56
Colon Cancer 30,064 Disease Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 2 0.00 -1.00 0.01 0.57
Non Small Cell Lung Cancer 28,563 Disease Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 2 0.00 -1.00 0.01 0.58
Cholesterol 182,390 Disease Target 11-Beta-Hydroxylase 721 98 0.01 -0.93 0.14 0.61
Carcinoma 433,099 Disease Target 11-Beta-Hydroxylase 721 19 0.00 -0.99 0.03 0.54
Cancer 1,053,491 Disease Target 11-Beta-Hydroxylase 721 10 0.00 -0.99 0.01 0.51